The maturation of megakaryocytes in vivo requires polyploidization or repeated duplication of DNA without cytokinesis. As DNA replication and cytokinesis are tightly regulated in somatic cells by cyclins and cyclin-dependent kinases, w e sought t o determine the pattern of cyclin gene expression in cells that undergo megakaryocytic differentiation and polyploidization. The Dami megakaryocytic cell line differentiates and increases ploidy in response t o phorbol 12-myristate 13-acetate (PMA) stimulation in vitro. We used Northern blotting t o analyze mRNA levels of cyclins A, B, C, Dl, and E in PMA-induced Dami cells and found that cyclin D l mRNA levels increased dramatically (l&fold). Similar increases in cyclin D1 mRNA were obtained for other cell lines (HEL and K562) with megakaryocytic properties, but not in HeLa cells. The increase in cyclin D1 was confirmed by West-ORMAL HEMOSTASIS requires an adequate number of blood platelets, which are derived from bone marrow megakaryocytes. Megakaryocytopoiesis is a complex process whereby proliferation and differentiation of precursor cells (pluripotent stem cells) result in mature, nondividing megakaryocytes that possess nuclear polyploidization, increased cell size, and increased cytoplasmic mass. Several different classes of human megakaryocyte precursor cells have been identified. The most primitive is the burst-forming unit-megakaryocyte (BFU-MK), which expresses the early hematopoietic marker CD34.'** These cells use at least two growth factors for proliferation, interleukin-3 (IL-3) and thrombopoietin (TP0)-like
ern immunoblotting of PMA-treated Dami cells. This finding suggested that cyclin D1 might participate in megakaryocyte differentiation by promoting endomitosis andlor inhibiting cell division. To address these possibilities, we constructed two stable Zn+z-inducible, cyclin Dl-overexpressing Dami cell lines. Cyclin D l expression alone was not sufficient t o induce polyploidy, but in conjunction with PMA-induced differentiation, polyploidization was slightly enhanced. However, unlike other cell systems, cyclin D l overexpression caused cessation of cell growth. Although the mechanism by which cyclin D l may affect megakaryocyte differentiation is not clear, these data demonstrate that cyclin D l is upregulated in differentiating megakaryocytic cells and may contribute to differentiation by arresting cell proliferation. hematopoietic cell lineages. CFC-MK give rise to megakaryocytes, which cease to undergo cytokinesis yet continue to replicate their DNA up to 128N (become polyploid cells) in vivo'2,2' "a process called polyploidization, or endomitosis.
The cellular mechanisms that allow mature megakaryocytes to bypass mitosis and continue to replicate DNA are unknown.
Megakaryocyte research is hampered by the fact that human megakaryocytes constitute only 0.03% to 0.06% of nucleated bone marrow cells and are difficult to isolate and maintain in culture. The discovery of leukemic cell lines with megakaryocyte-like properties (eg, HEL, Dami, MEGOls, and K562 cells) has made it possible to perform more detailed studies of megakaryocyte differentiati~n.~~.~' These cell lines have been used to clone and study the biosynthesis of megakaryocyte-specific genes. In addition, phorbol 12-myristate 13-acetate (PMA) is known to induce these cells toward a more differentiated phenotype and to upregulate the expression of certain megakaryocytic genes.",30,'2 For example, Long et a132 have shown that PMA-stimulation of HEL cells produces substantial increases in the number of cells of greater size, the nucleus-to-cytoplasm ratio, plateletassociated proteins, and DNA content per cell. PMA stimulation mimics the actions of hematopoietic growth factors (such as erythropoietin, TPO, IL-3, and TSF) in stimulating maturation of ~negakaryocytes.~~.~~ PMA has also been shown to increase the ploidy of Dami cells. 30 For all these reasons, PMA stimulation of megakaryocytic cell lines provides a useful model for megakaryocyte differentiation and polyploidization in vitro.
Megakaryocyte differentiation may involve altered cyclin gene expression. Most eukaryotic cells, megakaryocyte precursor cells included, undergo mitosis after DNA replication. However, in a dramatic alteration of the typical cell cycle, mature megakaryocytes bypass mitosis after DNA replication. Because progression through the cell cycle is regulated by cyclins and cyclin-dependent it is reasonable to consider that alterations in cycIin expression andor cyclindependent kinases exist in polyploid megakaryocytes. At least two crucial control points have been established in the basic cell cycle.'6 One checkpoint is the completion of S phase before entry into mitosis, and the second checkpoint is the completion of mitosis before entry into S phase. There is strong evidence that entry of mammalian cells into S phase from G1 involves the G1 cyclins, cyclins A, D1,37-39 and E.40.4' Cyclin A is also required for initiation of S Entry of cells into G2 and completion of mitosis involve elevation of cyclin B followed by degradation of cyclin A; cyclin B degradation causes cells to exit mit~sis."~'
As mature megakaryocytes do not undergo mitosis and as little information exists on the cyclin pattern exhibited in these cells, we used Dami cells as a model to investigate the roles of cyclins A, B 1, C, Dl, and E in megakaryocyte development. We found an l&fold increase in cyclin D l mRNA levels in PMA-induced Dami cells. Overexpression of cyclin Dl in transfected Dami cells was itself not sufficient to induce polyploidization. However, overexpression of cyclin DL caused cessation of cell growth in this system. Thus, although we began our studies intending to investigate possible mechanisms directly responsible for polyploidization, our results suggest a role for cyclin Dl in megakaryocyte differentiation that secondarily affects endomitosis.
MATERIALS AND METHODS
Cell lines and culture conditions. Dami cells3" (American Type Culture Collection [ATCC], Rockville, MD) were grown in Iscove's modified Dulbecco's medium (GIBCO BRL, Grand Island, NY) containing 10% vollvol horse serum (GIBCO BRL). HEL and K562 (ATCC) cell lines were maintained in RPM1 medium (GIBCO BRL) plus 10% fetal bovine serum (GIBCO BRL). HeLa cells (ATCC) were cultured in Dulbecco's modified Eagle's medium (DMEM) (GIBCO BRL) and 10% vollvol fetal bovine serum (GIBCO BRL). Cultures were maintained in a humidified atmosphere of 5% COz at 37°C.
To determine growth curves, cells were seeded at 0.5 X 10' cells/ mL in 10 mL of complete media and cultured in 100-mm2 tissue culture dishes. Cell counts were made using the trypan blue dye exclusion method.
Synchronization of cells was accomplished by adding Aphihcolin (5 pg/mL, Sigma, St Louis, MO) to 5 X lo5 cells in 10 mL complete media for 18 hours followed by washing three times with phosphatebuffered saline (PBS) (pH 7.4; 0.12 m o m NaCI, 8.0 mmol/L Na2HP04, 1.5 mmoVL KH2P04, 3.0 mmom KCI). Propidium iodide (PI) staining (see below) was performed to assure that the cells had stopped at the Cl-S phase of the cell cycle.
PMA stimulation. PMA (Sigma) was diluted to 1 mg/mL in dimethyl sulfoxide (DMSO; Sigma), and aliquots of 0.05 mL were frozen at -80°C. Cells (5 X l@/mL) were treated with 10, 100, or 1, OOO nmom PMA for specified times, and DMSO was adjusted to 0.25% of the final volume. To remove the adherent cells from flasks, cultures were washed once with 3 mL PBS and treated with 3 mL PBS plus 2.5 mmoVL EDTA. Cultures were incubated for 5 minutes at 37°C and washed three times with PBS. Viable cells were assessed by the trypan blue dye exclusion method. Cells were either fixed in 70% ethanol for PI staining, frozen at -70°C for Northern analysis, or lysed for Western analysis (see below).
PI staining. Ploidy was determined by PI staining using a modification of a published pr~cedure.~' Briefly, after PMA stimulation, cells were washed three times with PBS, centrifuged, and fixed in 3 mL 70% ethanol for at least 2 hours at 4°C. Cells were centrifuged, washed again in PBS, and incubated with 0.1 mg/mL DNase free RNAse (Boehringer Mannheim, Indianapolis, IN) in PBS for 30 minutes at 37°C. After washing twice in PBS, cells were resuspended in 0.01 mg/mL PI (Sigma) in PBS, incubated on ice for 30 6 .81, and polypeptides were resolved by 12% SDS-polyacrylamide gel electrophoresis (PAGE). Immunoblot analysis was performed using a rabbit antihuman cyclin D l antibody (1:500 dilution; Pharminogen, San Diego, CA) followed by incubation of the blots with a secondary goat antirabbit horseradish-peroxidase-conjugated antibody (Bio-Rad; 1: 1, OOO dilution). Reactive proteins were detected by the enhanced chemiluminescence (ECL) system (Amersham, Arlington Heights, IL). Luminograms were prepared by exposing immunoblots to Xray film for 1 to 60 seconds. The ability of the two cell lines with the highest levels of Zn+'-inducible cyclin D1 mRNA expression to produce cyclin D l protein was tested by treatment with 50 pmoVL Zn+' for 24 hours.
Development of stable cyclin Dl-overexpressing Dami cell lines. The parent plasmid for these experiments was pMT-CB6+ (a gift from F. Rauscher, The Wistar Institute, Philadelphia, PA), which contains a sheep metallothionein promoter and a neomycin-resistant marker gene. Plasmid pMTCycDl was constructed in the following fashion: a 1.25-kb full-length human cyclin D l cDNA was released from the pBS (Stratagene) shuttle vector by Not I digestion, gelpurified, and engineered into the Not I site downstream of the metallothionein promoter in pMT-CB6+. All plasmids were prepared through cesium chloride gradients. Circularized plasmid DNA (20 pg) in the presence of 40 pg of salmon sperm DNA (Sigma) was electroporated into lo7 Dami cells using a gene pulser (Bio-Rad) at 500 pF, 400 V, and time constants between 7.4 and 8.0 milliseconds. Neomycin-resistant cells were selected in complete media with the antibiotic G418 (GIBCO BRL) at 800 pg/mL for 10 days, followed by 600 pg/mL for 5 days, and the resulting stable cell lines were maintained in 400 pg/mL of G418 in complete media. A control cell line, Neo-l, was generated by transfecting the pMT-CB6+ vec- tor alone. Single-cell clones were generated by the limiting dilution method.
RESULTS
Increased polyploidy with PMA-induced megakaryocytic differentiation. To study the cyclin gene expression pattern of differentiating megakaryocytes, we used polyploidization as a reliable marker for megakaryocyte maturation. Such an approach has been used by other investigators with HEL cells.32 In a series of preliminary experiments using different culture conditions, we were able to achieve a maximal polyploid state in unsynchronized Dami cells with 100 nmol/L PMA in the presence of 10% serum at 24 hours (data not shown). These preliminary studies were performed on exponentially growing cultures in which cells were in different phases of the cell cycle (hence both 2N and 4N populations were seen at 0 hours). Because such a mixed population of cells would have random quantities of the various cyclins, we wanted to examine the ploidy of cells that had been synchronized in the cell cycle at the onset of PMA induction. Cells were synchronized at the G1-S phase by aphidicolin treatment (Fig 1D) . Aphidicolin treatment did not alter the overall ploidal distribution of PMA-induced cells compared with nonaphidicolin-treated cells (Fig IB through F) . In addition, both synchronized and nonsynchronized cells showed a substantial increase in the number of polyploid cells after 24 hours of treatment with PMA (Fig IC and F) .
Several controls were performed to verify these findings. As PMA must be suspended in DMSO, we tested for an effect of DMSO alone. Compared with 0 hours, no significant increase in ploidy was observed after 24 hours of 0.25% DMSO treatment (Fig 1A  through E) . In addition, cells treated with this amount of DMSO showed no morphologic evidence of megakaryocyte differentiation by light microscopy and proliferated at the same rate as untreated cells (data not shown). To rule out cellular fusion as the mechanism of PMA-induced increase in DNA content, cell counts were carefully monitored before and after PMA addition. No decrease in cell number was ever observed after l hour of PMA stimulation, indicating that cell fusion was unlikely. The distinct separation of twofold multiples of ploidy peaks in Fig IC and F also indicates a lack of significant cell fusion: as fusion would be random, there would be some populations of multiples of three. Because cell aggregates could also be misinterpreted as an increase in cell DNA content, we confirmed that flow cytometry was performed on single-cell suspensions both by forward light scatter (a measurement of cell size) during fluorescence-activated cell sorter (FACS) analysis and by light microscopy. Lastly, PMA-induced polyploidy was verified by quantitating genomic DNA from PMA-induced cells. After 20 hours (one cell division), the DNA content per cell had doubled both by optical density reading of extracted genomic DNA (data not shown) and by PI staining. Using HEL cells, Long et al" have performed similar and additional studies to demonstrate a lack of significant cell fusion after PMA induction. (Fig 2A) . There was little change in mRNA accumulation for cyclins A and C at any time point (Fig 2A through C) . Cyclin B and cyclin E mRNA levels rose 18-fold and two-to fourfold, respectively, in both control cells and those treated with PMA (Fig 2C) , suggesting no obvious relationship to differentiation or polyploidization in this system. There was no increase in cyclin Dl mRNA expression caused by DMSO treatment alone (Fig 2B) , whereas there was a steady rise in the level of cyclin D1
mRNA to an 18-fold increase at 12 hours, declining to a ninefold increase at 24 hours (Fig 2C) . These changes occurred in nondividing cells, as cell numbers did not change between the 0-hour and 24-hour time points (data not shown). Similar results were obtained for cyclin D1 mRNA expression in PMA-induced Dami cells that were not synchronized by aphidicolin treatment (data not shown), indicating that the increase in cyclin D1 mRNA was not an artifact of aphidicolin treatment. Importantly, the increase in cyclin D 1 mRNA corresponded to an increase in cyclin D 1 protein by Western immunoblot analysis (Fig 2D) . These data indicate a dramatic increase in cyclin D1 mRNA and pfotein levels after PMA stimulation of Dami cells under conditions that induced differentiation as assessed by increases in cell ploidy.
As c-myc expression has been linked to cellular proliferation, we also determined its expression during the differentiation of Dami cells. We observed a slight increase in c-myc mRNA levels after 4 hours of PMA induction, but then the level decreased at 8 hours and continued to decrease up to 24 hours (Fig 2C) . This decrease persisted for up to 6 days of PMA treatment (data not shown) and is consistent with the data reported by others.3z
Cyclin D l mRNA accumulation increases during dlfferentiation in other cells with megakaryocytic properties. Two other megakaryocytic cell lines, HEL and K562, showed similar increases in cyclin Dl mRNA level in response to PMA (Fig 3 and Table 1) . HEL cells showed a 30-fold increase in cyclin D1 mRNA levels at 12 hours of PMA treatment compared with the DMSO control, and K562 cells showed a ninefold increase in response to PMA compared with the DMSO control. The nonmegakaryocytic cell line HeLa did not show an increase in cyclin D1 mRNA after 12 hours of PMA treatment compared with the DMSO control (Fig 3) and showed only a slight increase after 24 hours of PMA compared with the DMSO control ( Table l) . HeLa cells treated with PMA in this fashion displayed terminal differentiation as demonstrated by a cessation of cell division. Figure 3 also demonstrates that the basal levels of cyclin Dl in HeLa cells are higher than in the other lines tested (note especially the Dami cells). In addition, the absolute levels of cyclin D1 mRNA in HeLa and Dami cells treated with PMA for 24 hours is similar. These data suggest that it is the change in cyclin D1 level, rather than the absolute level, that may affect the cell cycle in a manner unique to differentiating megakaryocytic cell lines.
These findings led us to form an additional hypothesis: cyclin Dl may be involved in the differentiation of megakaryocytic cells by either promoting endomitosis and/or by blocking cell division. To address this hypothesis, we developed two stable Dami cell lines that could be induced to overexpress cyclin D 1.
Cyclin D l is not sufficient by itself to induce polyploidization. To examine the potential role of cyclin D1 in megakaryocyte endomitosis, Dami cells were transfected with an expression vector containing the sheep metallothionein pro- moter and a full-length human cyclin D1 cDNA. Two stable, Zn"-inducible Dami cell lines that overexpressed cyclin Dl were generated and designated D-l3 and D-15. Western analysis confirmed that cyclin D1 protein expression was inducible with Zn+* in lines D-l3 and D-l5 (Fig 4A, lanes   4 and 6) but not in the control (neomycin-resistant) lines (Fig 4A, lane 8) . Note also the substantial increase in cyclin D1 expression in the inducible cell lines compared with the parental (lane 2) or control (lane 9) lines treated with PMA. To determine if overexpression of cyclin D1 would raise the ploidy independent of PMA induction, we performed PI staining on clones D-13, D-15, and Neo-l after treatment with Znf2. The slight shift in ploidy from 2N to 4N seen after 24 hours of Zn+' treatment was similar among clones D-13, D-15, and the control Neo-l (Fig 4B) . Thus, overexpression of cyclin D1 protein for 24 hours was not sufficient to increase the DNA content of Dami cells. Zn+2 itself did not suppress polyploidy, because Zn+' does not diminish the normal increase in polyploidy observed when the parental increase in the degree and number of polyploid cells compared with stimulation with PMA alone (Fig 5) . Although the increase in cyclin D 1 -induced polyploidization was minimal, it was reproducible in four separate experiments. Furthermore, reducing the serum concentration to 0.5% slightly enhanced the cyclin D l effect on endomitosis (data not shown), suggesting the increase in ploidy was not due to a serum factor. In this experiment, we observed a less-thanexpected increase in ploidy with PMA stimulation of the Darni/Neo-l cell line. We believe this was due to a variable PMA effect but cannot rule out a possible toxic effect of the control plasmid vector. Nevertheless, because the additive effect of PMA on cyclin D l overexpression can only be compared within a given experiment, the data in Fig 5 con- tain sufficient information to demonstrate a slight increase in the number of polyploid cells.
Overexpression of cyclin D l inhibits cell division. We next determined the patterns of growth in cells overexpressing cyclin Dl. G1-S phase transition, thereby accelerating progression through the cell cycle. The mechanism by which cyclin Dl would exert such an effect has yet to be determined, but this unusual behavior in cells with megakaryocytic features is an important finding.
As oscillating cyclin expression is pivotal in the cell division cycle of other somatic cells, alterations of cyclins and associated kinases or their gene expression may underlie the mechanism that promotes endomitosis in maturing megakaryocytes. The entry of cells into S-phase is regulated in part by the expression of cyclins A, D, and E that associate with specific catalytic kinase subunits. Exit from S-phase requires completion of DNA synthesis and proofreading of the replicated DNA. Entry into G2, the second gap that precedes mitosis, is associated with disappearance of cyclin A and the persistence of cyclin B, whose expression increases during S-pha~e.~' Entry into mitosis involves a checking mechanism that monitors chromosomal symmetry at the metaphase plate, and exit from mitosis requires the degradation of cyclin B. As cyclins A, E, and B are implicated in the regulation of DNA synthesis and mitosis, we sought to determine whether the expression of these cyclins are altered during polyploidization of a megakaryocytic cell line. Specifically, we hypothesized that cyclin A and E expression might he elevated, whereas cyclin B expression could he blunted with polyploidization.
In contrast to our initial hypothesis, we found that cyclin A and cyclin B mRNA levels did not vary dramatically in PMA-induced polyploid Dami cells compared with nondifferentiated Dami cells. However, we observed a positive correlation between megakaryocytic differentiation and cyclin D l expression (Fig 2A and D) . Cumulative evidence suggests that cyclin D l expression is crucial for traversal through the G1 phase of the cell cycle. In fact, cyclin D1 was discovered by its ability to rescue yeast mutants defective in GL'','~ Moreover, cyclin Dl expression is increased during G1 by growth factor stimulation of several cell lines. 37, 38, 54, 55 In our studies, there was an 18-fold increase in mRNA levels of cyclin D l in Dami cells that were induced to polyploidy by PMA while there was no detectable increase in control cells (Fig 2B and C) . We observed a corresponding increase in cyclin D l protein but were only able to detect cyclin Dl by immunoblot analysis in our nonoverexpressing cells ( Fig  2D) with prolonged film exposures. It has generally been assumed that cyclin D l mRNA levels correlate with protein expression:6 and our studies showed a direct correlation (Fig 2D) . To determine whether cyclin Dl participates in polyploidization, inducible, cyclin D 1 -overexpressing Dami cells were generated. We found that cyclin Dl alone was insufficient to induce polyploidization. The increased DNA content of Dami cells that are differentiated by PMA and that overexpress cyclin Dl (Fig 5) is minimal, and we hesitate to attach significance to this. Additional studies (such as blocking cyclin D l activity, determining levels of the CDK4 or CDK6 partner kinase for cyclin Dl, or examining the association of cyclin D l with CDK2 and cyclin-dependent kinase inhibitors) would more fully address the role of this cyclin in endoreduplication. Likewise, the generation of additional cyclin Dl-overexpressing lines in other megakaryocytic and nonmegakaryocytic cell lines would be instructive.
Previous work inducing endomitosis in megakaryocytic cell lines was performed by culturing cells in either 0.5% or 10% serum in the presence of 2 to 10 nmol/L PMA."-" Under these conditions, cells achieve low levels of polyploidy after 3 days. Using Dami cells, we found that PMA at 10 nmol/L concentration in the presence of 10% serum did not increase polyploidy substantially at 24 or 48 hours; however, there were small increases detected after 72 hours. In contrast, treatment with 100 nmol/L PMA for 24 and 48 hours had substantially increased ploidy. There was virtually no difference in the extent of endomitosis for cells induced with either 100 or 1,000 nmol/L PMA. Compared with cells that were treated with PMA in the presence of 0.5% serum, the 10% serum concentration caused 2N and 4N cells to shift to a higher ploidy at an earlier time (24 hours) and caused a more pronounced shift to cells that were 8N or higher. By day 3, many of the PMA-induced Dami cells exhibited typical morphologic characteristics of differentiated megakaryocytes (eg, increased cell size, marked nuclear lobulation, and increased cytoplasmic content), a finding previously noted in Dami," Meg-01,3' and HEL32 cells. As an additional marker for megakaryocyte differentiation, we observed an increase in GPIIIa mRNA in PMA-treated, polyploid Dami cells compared with untreated cells (data not shown).
There are a number of growth factors that would be interesting to study in the context of our results, particularly the c-mpl ligand (TPO, megakaryocyte growth and development factor), which has been shown to act at an early stage in megakaryocyte differentiation and to induce ploidization. 6 Now that the c-mpl ligand has been cl0ned,5.~,'~ cyclin Dl expression in CD34' cells isolated from human bone marrow and treated with and without this growth factor can be studied using primary human megakaryocytes.
Overexpression of cyclin Dl has been shown to shorten the G1 phase of transfected fib rob last^,^' and numerous studies suggest it contributes to the growth of different For these reasons, it has generally been believed that the primary effect of cyclin D l was to stimulate cell g r~w t h .~~,~~ In our studies, induced cyclin D l expression in Dami cells resulted in cessation of cell growth (Fig 6) . Overexpression of cyclin Dl did not cause the Dami cells to accumulate at the G1-S phase or at any particular phase of the cell cycle; rather, growth appeared to stop in all phases of the cell cycle. Quelle et a139 inferred that very high levels of cyclin D l might be toxic to cells based on the inability to obtain cell lines using certain retroviral expression vectors. We have no way of comparing the levels of cyclin Dl expression that we obtained with those of other investigators. There are other differences between our study and that of Quelle et a139 (eg, the species origin of cells and cyclin D l used), but it is sufficient to note that, in contrast to its pivotal role in the proliferation of other cells, we observed that markedly elevated cyclin D l expression correlates with the differentiation of a megakaryocytic cell line. Specifically, our data indicate that cyclin D l expression persists in PMA-stimulated Dami cells beyond the G1-S boundary, as its expression peaks at 12 hours, and DNA replication initiates at 4 hours after G1 arrest. These results strongly suggest that cyclin Dl functions quite differently in Dami cells as compared with its growthpromoting effects in other cells. The process by which differentiating megakaryocytes become polyploid is still not understood. We have found that cyclin Dl is upregulated in response to PMA in three megakaryocytic cell lines, Dami, HEL, and K562, while the nonmegakaryocytic cell line HeLa shows little increase in cyclin Dl in response to PMA. Other investigators have shown that the peak cyclin D l mRNA level in serum-induced HeLa cells is detected at mitosis, compared with G1 in fibroblast~.'~,'' Our data show that PMA did not substantially increase levels of HeLa cyclin D l mRNA at 12 or 24 hours post-G, synchronization compared with DMSO-treated cells sampled at the same time (0.5-and 1.8-fold increases, respectively). In contrast, Dami, HEL, and K562 cell lines showed substantial increases of cyclin D l mRNA levels in response to PMA (Table 1) . PMA-induced increases in cyclin D l mRNA levels have been observed in two megakaryocytic cell lines (HEL and CMK cells) and in promyelocytic HL-60 cells. 66 We have now demonstrated the corresponding increase in cyclin D l protein levels. Akiyama et a166 used different concentrations of PMA (in fact, 50% more in HL-60 v HEL cells), did not examine DNA content in any of the cell lines they studied, and did not describe the growth rate of the HL-60 cells. The CMK cells actually increased in number after PMA treatment, indicating cell division was continuing. In our system, cell division ceased, and we are able to conclude that cyclin Dl levels increased in nondividing cells. Collectively, these observations suggest a diversity of cyclin Dl function in different cell types and, in particular, that cyclin D l may be an important mediator of differentiation in certain cell types, such as megakaryocytic cells. Finally, it is tempting to speculate that cyclin Dl may contribute to megakaryocyte differentiation by arresting cell proliferation while DNA synthesis continues.
